A critical discovery in cancer investigation is emerging with the use of VHH fragments to re-engage dysfunctional p53. This vital cancer protector protein is frequently inactivated in various types of tumors, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research